NCT02462720View on ClinicalTrials.gov

COMFORT: A Multicenter, Open-label, Randomized, Crossover Study

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2016

Conditions
Varicose Veins
Interventions
DRUG

Varithena®

Varithena® treatment in accordance with full prescribing information and instructions for use

DEVICE

Radiofrequency ablation

Radiofrequency ablation conducted per physicians' standard of care.

Trial Locations (4)

14226

Venous Institute of Buffalo, Amherst

32503

Coastal Vascular and Interventional, PLLC, Pensacola

60160

Midwest Institute for Minimally Invasive Therapies, Melrose Park

98004

Lake Washington Vascular, Bellevue

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY